Corrigendum (Ophthalmology (2019) 126(1) (P216–P285), (S0161642018326496), (10.1016/j.ophtha.2018.10.022));Corneal Edema and Opacification Preferred Practice Pattern®

Ophthalmology

Volumn 126, Issue 1, 2019, Pages P216-P285

  Farid, Marjan ^a   Rhee, Michelle K ^b   Akpek, Esen K ^c   Amescua, Guillermo ^d   Garcia Ferrer, Francisco J ^e   Lin, Amy ^f   Varu, Divya M ^g   Musch, David C ^h   Mah, Francis S ⁱ   Dunn, Steven P ^j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Mercy Clinic and Hospital   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g Dell Laser Consultants   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ SCRIPPS CLINIC   (United States)

^j PC ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMNION; ANTERIOR LAMELLAR KERATOPLASTY; ANTERIOR LAMELLAR THERAPEUTIC KERATOPLASTY; ARTICLE; CLINICAL PRACTICE; CORNEA DISEASE; CORNEA EDEMA; CORNEA TRANSPLANTATION; CORNEAL OPACIFICATION; DEBRIDEMENT; DEEP ANTERIOR LAMELLAR KERATOPLASTY; ENDOTHELIAL KERATOPLASTY; FOLLOW UP; HUMAN; KERATECTOMY; KERATOPATHY; KERATOPLASTY; MEDICAL HISTORY; PENETRATING KERATOPLASTY; PHOTOTHERAPEUTIC KERATECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SOCIOECONOMICS; TISSUE TRANSPLANTATION; TREATMENT OUTCOME; CORNEA OPACITY; CORNEAL PACHYMETRY; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; OPHTHALMOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; SLIT LAMP MICROSCOPY; UNITED STATES;

ACADEMIES AND INSTITUTES; CORNEAL EDEMA; CORNEAL OPACITY; CORNEAL PACHYMETRY; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; HUMANS; KERATOPLASTY, PENETRATING; OPHTHALMOLOGY; PHYSICAL EXAMINATION; PRACTICE PATTERNS, PHYSICIANS'; SLIT LAMP MICROSCOPY; UNITED STATES;

EID: 85055189301     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2020.02.013     Document Type: Erratum

References (242)

1. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook. Edinburgh: SIGN; 2015. (SIGN publication no. 50). [November 2015]. Available from URL: http://www.sign.ac.uk.
2. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
3. GRADE Working Group. Organizations that have endorsed or that are using GRADE. http://www.gradeworkinggroup.org/. Accessed September 19, 2018.
4. Schmid KE, Kornek GV, Scheithauer W, Binder S. Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol. 2006;51(1):19-40.
5. Feder RS, Olsen TW, Prum BE, Jr., et al. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern((R)) Guidelines. Ophthalmology. 2016;123(1):P209-236. www.aaojournal.org/content/preferredpractice-pattern or www.aao.org/ppp. Accessed May 230, 2017.
6. Nevyas AS, Raber IM, Eagle RC, Jr., Wallace IB, Nevyas HJ. Acute band keratopathy following intracameral Viscoat. Arch Ophthalmol. 1987;105(7):958-964.
7. Freddo TF, Leibowitz HM. Bilateral acute corneal calcification. Ophthalmology. 1985;92(4):537-542.
8. Honig MA, Barraquer J, Perry HD, Riquelme JL, Green WR. Forceps and vacuum injuries to the cornea: histopathologic features of twelve cases and review of the literature. Cornea. 1996;15(5):463-472.
9. Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab. 2000;71(1-2):100-120.
10. Summers CG, Purple RL, Krivit W, et al. Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report. Ophthalmology. 1989;96(7):977-984; discussion 984-975.
11. van der Meulen IJ, Patel SV, Lapid-Gortzak R, Nieuwendaal CP, McLaren JW, van den Berg TJ. Quality of vision in patients with Fuchs endothelial dystrophy and after Descemet stripping endothelial keratoplasty. Arch Ophthalmol. 2011;129(12):1537-1542.
12. Wacker K, McLaren JW, Amin SR, Baratz KH, Patel SV. Corneal high-order aberrations and backscatter in Fuchs' endothelial corneal dystrophy. Ophthalmology. 2015;122(8):1645-1652.
13. Jeng BH, Galor A, Lee MS, et al. Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology. 2008;115(9):1540-1544.
14. Naumann GO, Schlotzer-Schrehardt U. Amantadine-associated corneal edema. Ophthalmology. 2009;116(6):1230-1231; author reply 1231.
15. Park CY, Chuck RS. Sudden bilateral corneal oedema in a patient with Parkinson's disease. Acta Ophthalmol. 2011;89(2):198-199.
16. Varley GA, Meisler DM, Benes SC, McMahon JT, Zakov ZN, Fryczkowski A. Hibiclens keratopathy: a clinicopathologic case report. Cornea. 1990;9(4):341-346.
17. Raizman MB, Hamrah P, Holland EJ, et al. Drug-induced corneal epithelial changes. Surv Ophthalmol. 2017;62(3):286-301.
18. Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127-141.
19. Kaplan LJ, Cappaert WE. Amiodarone keratopathy. Correlation to dosage and duration. Arch Ophthalmol. 1982;100(4):601-602.
20. Jhanji V, Rapuano CJ, Vajpayee RB. Corneal calcific band keratopathy. Curr Opin Ophthalmol. 2011;22(4):283-289.
21. Jeganathan VS, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 2011;79(3):650-659.
22. Smith GT, Deutsch GP, Cree IA, Liu CS. Permanent corneal limbal stem cell dysfunction following radiotherapy for orbital lymphoma. Eye (Lond). 2000;14(Pt 6):905-907.
23. Papathanassiou M, Nikita E, Theodossiadis P, Theodossiadis GP, Vergados I. Exemestane-induced corneal epithelial changes. Cutan Ocul Toxicol. 2010;29(3):209-211.
24. Yeh S, Fine HA, Smith JA. Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma. Cornea. 2009;28(6):699-702.
25. Van Meter WS. Central corneal opacification resulting from recent chemotherapy in corneal donors. Trans Am Ophthalmol Soc. 2007;105:207-212; discussion 212-203.
26. Serle JB, Katz LJ, McLaurin E, et al. Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2). Am J Ophthalmol. 2018;186:116-127.
27. Miglior S, Albe E, Guareschi M, Mandelli G, Gomarasca S, Orzalesi N. Intraobserver and interobserver reproducibility in the evaluation of ultrasonic pachymetry measurements of central corneal thickness. Br J Ophthalmol. 2004;88(2):174-177.
28. Garcia-Medina JJ, Garcia-Medina M, Garcia-Maturana C, Zanon-Moreno V, Pons-Vazquez S, Pinazo-Duran MD. Comparative study of central corneal thickness using fourier-domain optical coherence tomography versus ultrasound pachymetry in primary open-angle glaucoma. Cornea. 2013;32(1):9-13.
29. Fante RJ, Shtein RM, Titus MS, Woodward MA. Anterior segment optical coherence tomography versus ultrasound pachymetry to measure corneal thickness in endothelial keratoplasty donor corneas. Cornea. 2013;32:e79-82.
30. Wirbelauer C, Scholz C, Hoerauf H, Pham DT, Laqua H, Birngruber R. Noncontact corneal pachymetry with slit lamp-adapted optical coherence tomography. Am J Ophthalmol. 2002;133(4):444-450.
31. Zhao PS, Wong TY, Wong WL, Saw SM, Aung T. Comparison of central corneal thickness measurements by visante anterior segment optical coherence tomography with ultrasound pachymetry. Am J Ophthalmol. 2007;143(6):1047-1049.
32. Kim HY, Budenz DL, Lee PS, Feuer WJ, Barton K. Comparison of central corneal thickness using anterior segment optical coherence tomography vs ultrasound pachymetry. Am J Ophthalmol. 2008;145(2):228-232.
33. Brandt JD, Beiser JA, Kass MA, Gordon MO. Ocular Hypertension Treatment Study (OHTS) Group. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108(10):1779-1788.
34. Iyamu E, Osuobeni E. Age, gender, corneal diameter, corneal curvature and central corneal thickness in Nigerians with normal intra ocular pressure. J Optom. 2012;5:87-97.
35. ® Guidelines. Corneal Ectasia. San Francisco, CA: American Academy of Ophthalmology; 2018. www.aao.org/ppp.
36. Hirst LW, Yamauchi K, Enger C, Vogelpohl W, Whittington V. Quantitative analysis of wide-field specular microscopy. II. Precision of sampling from the central corneal endothelium. Invest Ophthalmol Vis Sci. 1989;30(9):1972-1979.
37. Mustonen RK, McDonald MB, Srivannaboon S, Tan AL, Doubrava MW, Kim CK. In vivo confocal microscopy of Fuchs' endothelial dystrophy. Cornea. 1998;17(5):493-503.
38. Edelhauser HF. The balance between corneal transparency and edema: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;47(5):1754-1767.
39. Alm A, Grierson I, Shields MB. Side effects associated with prostaglandin analog therapy. Surv Ophthalmol. 2008;53 Suppl 1:S93-105.
40. Aydin S, Ozcura F. Corneal oedema and acute anterior uveitis after two doses of travoprost. Acta Ophthalmol Scand. 2007;85(6):693-694.
41. Wirtitsch MG, Findl O, Heinzl H, Drexler W. Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol. 2007;125(10):1345-1350.
42. Egan CA, Hodge DO, McLaren JW, Bourne WM. Effect of dorzolamide on corneal endothelial function in normal human eyes. Invest Ophthalmol Vis Sci. 1998;39(1):23-29.
43. Foulks GN, Harvey T, Raj CV. Therapeutic contact lenses: the role of high-Dk lenses. Ophthalmol Clin North Am. 2003;16(3):455-461.
44. Luchs JI, Cohen EJ, Rapuano CJ, Laibson PR. Ulcerative keratitis in bullous keratopathy. Ophthalmology. 1997;104(5):816-822.
45. DeVoe AG. Electrocautery of Bowman's membrane. Arch Ophthalmol. 1966;76(6):768-771.
46. Cormier G, Brunette I, Boisjoly HM, LeFrancois M, Shi ZH, Guertin MC. Anterior stromal punctures for bullous keratopathy. Arch Ophthalmol. 1996;114(6):654-658.
47. Wood TO, McLaughlin BJ, Boykins LG. Electron microscopy of corneal surface microdiathermy. Curr Eye Res. 1985;4(8):885-895.
48. Maini R, Sullivan L, Snibson GR, Taylor HR, Loughnan MS. A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy. Br J Ophthalmol. 2001;85(8):912-915.
49. Rosa N, Cennamo G. Phototherapeutic keratectomy for relief of pain in patients with pseudophakic corneal edema. J Refract Surg. 2002;18(3):276-279.
50. Lin PY, Wu CC, Lee SM. Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy. Br J Ophthalmol. 2001;85(8):908-911.
51. Chawla B, Sharma N, Tandon R, Kalaivani M, Titiyal JS, Vajpayee RB. Comparative evaluation of phototherapeutic keratectomy and amniotic membrane transplantation for management of symptomatic chronic bullous keratopathy. Cornea. 2010;29(9):976-979.
52. Mannan R, Pruthi A, Rampal U. Combined phototherapeutic keratectomy and amniotic membrane grafts for symptomatic bullous keratopathy. Cornea. 2010;29(10):1207-1208; author reply 1208-1209.
53. Thomann U, Meier-Gibbons F, Schipper I. Phototherapeutic keratectomy for bullous keratopathy. Br J Ophthalmol. 1995;79(4):335-338.
54. Koenig SB. Annular keratotomy for the treatment of painful bullous keratopathy. Am J Ophthalmol. 1996;121(1):93-94.
55. Gundersen T. Conjunctival flaps in the treatment of corneal disease with reference to a new technique of application. AMA Arch Ophthalmol. 1958;60(5):880-888.
56. Guell JL, Morral M, Gris O, Elies D, Manero F. Treatment of symptomatic bullous keratopathy with poor visual prognosis using a modified Gundersen conjunctival flap and amniotic membrane. Ophthalmic Surg Lasers Imaging. 2012;43(6):508-512.
57. Sonmez B, Kim BT, Aldave AJ. Amniotic membrane transplantation with anterior stromal micropuncture for treatment of painful bullous keratopathy in eyes with poor visual potential. Cornea. 2007;26(2):227-229.
58. Espana EM, Grueterich M, Sandoval H, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29(2):279-284.
59. Pires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999;117(10):1291-1297.
60. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002;21(4):342-345.
61. Georgiadis NS, Ziakas NG, Boboridis KG, Terzidou C, Mikropoulos DG. Cryopreserved amniotic membrane transplantation for the management of symptomatic bullous keratopathy. Clin Experiment Ophthalmol. 2008;36(2):130-135.
62. Pavlovic I, Shajari M, Herrmann E, Schmack I, Lencova A, Kohnen T. Meta-analysis of postoperative outcome parameters comparing descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Cornea. 2017;36(12):1445-1451.
63. Deng SX, Lee WB, Hammersmith KM, et al. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the american academy of ophthalmology. Ophthalmology. 2018;125(2):295-310.
64. Streilein JW. New thoughts on the immunology of corneal transplantation. Eye (Lond). 2003;17(8):943-948.
65. Jonas JB, Rank RM, Budde WM. Immunologic graft reactions after allogenic penetrating keratoplasty. Am J Ophthalmol. 2002;133(4):437-443.
66. Claesson M, Armitage WJ, Fagerholm P, Stenevi U. Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register. Br J Ophthalmol. 2002;86(2):174-180.
67. Allan BD, Terry MA, Price FW, Jr., Price MO, Griffin NB, Claesson M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea. 2007;26(9):1039-1042.
68. Wu EI, Ritterband DC, Yu G, Shields RA, Seedor JA. Graft rejection following descemet stripping automated endothelial keratoplasty: features, risk factors, and outcomes. Am J Ophthalmol. 2012;153(5):949-957.
69. Jordan CS, Price MO, Trespalacios R, Price FW, Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms. Br J Ophthalmol. 2009;93(3):387-390.
70. Price MO, Gorovoy M, Benetz BA, et al. Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study. Ophthalmology. 2010;117(3):438-444.
71. Price MO, Jordan CS, Moore G, Price FW, Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol. 2009;93(3):391-395.
72. Price MO, Scanameo A, Feng MT, Price FW, Jr. Descemet's membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids. Ophthalmology. 2016;123(6):1232-1236.
73. Sugar A, Tanner JP, Dontchev M, et al. Corneal Donor Study Investigator Group. Recipient risk factors for graft failure in the cornea donor study. Ophthalmology. 2009;116(6):1023-1028.
74. Price MO, Fairchild KM, Price DA, Price FW, Jr. Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss. Ophthalmology. 2011;118(4):725-729.
75. Thompson RW, Jr., Price MO, Bowers PJ, Price FW, Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110(7):1396-1402.
76. Elder MJ, Stack RR. Globe rupture following penetrating keratoplasty: how often, why, and what can we do to prevent it? Cornea. 2004;23(8):776-780.
77. Perl T, Charlton KH, Binder PS. Disparate diameter grafting. Astigmatism, intraocular pressure, and visual acuity. Ophthalmology. 1981;88(8):774-781.
78. Samples JR, Binder PS. Visual acuity, refractive error, and astigmatism following corneal transplantation for pseudophakic bullous keratopathy. Ophthalmology. 1985;92(11):1554-1560.
79. Troutman RC, Gaster RN. Surgical advances and results of keratoconus. Am J Ophthalmol. 1980;90(2):131-136.
80. Perlman EM. An analysis and interpretation of refractive errors after penetrating keratoplasty. Ophthalmology. 1981;88(1):39-45.
81. Lee WB, Jacobs DS, Musch DC, Kaufman SC, Reinhart WJ, Shtein RM. Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2009;116(9):1818-1830.
82. Price MO, Baig KM, Brubaker JW, Price FW, Jr. Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2008;146(1):36-41.
83. Covert DJ, Koenig SB. New triple procedure: Descemet's stripping and automated endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation. Ophthalmology. 2007;114(7):1272-1277.
84. Dickman MM, Kruit PJ, Remeijer L, et al. A randomized multicenter clinical trial of ultrathin descemet stripping automated endothelial keratoplasty (DSAEK) versus DSAEK. Ophthalmology. 2016;123(11):2276-2284.
85. von Marchtaler PV, Weller JM, Kruse FE, Tourtas T. Air versus sulfur hexafluoride gas tamponade in descemet membrane endothelial keratoplasty: a fellow eye comparison. Cornea. 2018;37(1):15-19.
86. Oellerich S, Baydoun L, Peraza-Nieves J, et al. Multicenter study of 6-month clinical outcomes after descemet membrane endothelial keratoplasty. Cornea. 2017;36(12):1467-1476.
87. Nagra PK, Hammersmith KM, Rapuano CJ, Laibson PR, Cohen EJ. Wound dehiscence after penetrating keratoplasty. Cornea. 2006;25(2):132-135.
88. Renucci AM, Marangon FB, Culbertson WW. Wound dehiscence after penetrating keratoplasty: clinical characteristics of 51 cases treated at Bascom Palmer Eye Institute. Cornea. 2006;25(5):524-529.
89. Ing JJ, Ing HH, Nelson LR, Hodge DO, Bourne WM. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998;105(10):1855-1865.
90. Hamzaoglu EC, Straiko MD, Mayko ZM, Sales CS, Terry MA. The first 100 eyes of standardized Descemet stripping automated endothelial keratoplasty versus standardized Descemet membrane endothelial keratoplasty. Ophthalmology. 2015;122(11):2193-2199.
91. Price MO, Giebel AW, Fairchild KM, Price FW, Jr. Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116(12):2361-2368.
92. Dapena I, Ham L, Droutsas K, van Dijk K, Moutsouris K, Melles GR. Learning curve in Descemet's membrane endothelial keratoplasty: first series of 135 consecutive cases. Ophthalmology. 2011;118(11):2147-2154.
93. Anshu A, Price MO, Price FW, Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012;119(3):536-540.
94. Price MO, Lisek M, Feng MT, Price FW, Jr. Effect of donor and recipient diabetes status on Descemet membrane endothelial keratoplasty adherence and survival. Cornea. 2017;36(10):1184-1188.
95. Forster RK. A comparison of two selective interrupted suture removal techniques for control of post keratoplasty astigmatism. Trans Am Ophthalmol Soc. 1997;95:193-214; discussion 214-120.
96. Dirisamer M, Ham L, Dapena I, et al. Efficacy of Descemet membrane endothelial keratoplasty: clinical outcome of 200 consecutive cases after a learning curve of 25 cases. Arch Ophthalmol. 2011;129(11):1435-1443.
97. Guerra FP, Anshu A, Price MO, Giebel AW, Price FW. Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011;118(12):2368-2373.
98. Serdarevic ON, Renard GJ, Pouliquen Y. Randomized clinical trial of penetrating keratoplasty. Before and after suture removal comparison of intraoperative and postoperative suture adjustment. Ophthalmology. 1995;102(10):1497-1503.
99. Bartels MC, van Rooij J, Geerards AJ, Mulder PG, Remeijer L. Comparison of complication rates and postoperative astigmatism between nylon and mersilene sutures for corneal transplants in patients with Fuchs endothelial dystrophy. Cornea. 2006;25(5):533-539.
100. Heidemann DG, Dunn SP, Chow CY. Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy. Cornea. 2008;27(2):161-167.
101. Ham L, Dapena I, Moutsouris K, et al. Refractive change and stability after Descemet membrane endothelial keratoplasty. Effect of corneal dehydration-induced hyperopic shift on intraocular lens power calculation. J Cataract Refract Surg. 2011;37(8):1455-1464.
102. Lass JH, Gal RL, Dontchev M, et al. Cornea Donor Study Investigator Group. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology. 2008;115(4):627-632.
103. Ham L, van Luijk C, Dapena I, et al. Endothelial cell density after descemet membrane endothelial keratoplasty: 1- to 2-year follow-up. Am J Ophthalmol. 2009;148(4):521-527.
104. Nanavaty MA, Wang X, Shortt AJ. Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy. Cochrane Database Syst Rev. 2014(2):CD008420.
105. Eye Bank Association of America. 2016 Eye banking statistical report. https://restoresight.org/what-wedo/publications/statistical-report/. Accessed March 1, 2018.
106. Price MO, Price FW, Jr. Descemet's membrane endothelial keratoplasty surgery: update on the evidence and hurdles to acceptance. Curr Opin Ophthalmol. 2013;24(4):329-335.
107. Yokogawa H, Sanchez PJ, Mayko ZM, Straiko MD, Terry MA. Corneal astigmatism stability in descemet membrane endothelial keratoplasty for fuchs corneal dystrophy. Cornea. 2016;35(7):932-937.
108. Veldman PB, Dye PK, Holiman JD, et al. The S-stamp in descemet membrane endothelial keratoplasty safely eliminates upside-down graft implantation. Ophthalmology. 2016;123(1):161-164.
109. Ampazas P, Droutsas K, Giallouros E, Schroeder FM, Sekundo W. Comparison of 5% sulfur hexafluoride versus 100% air tamponade in descemet membrane endothelial keratoplasty. Cornea. 2017;36(10):1189-1194.
110. Moloney G, Petsoglou C, Ball M, et al. Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil. Cornea. 2017;36(6):642-648.
111. Sanchez JC, Infantes Molina EJ, Cantos EA. Descemetorhexis without graft placement: transplant of descemet-free fragments. Ophthalmology. 2017;124(11):1620.
112. Kinoshita S, Koizumi N, Ueno M, et al. Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy. N Engl J Med. 2018;378(11):995-1003.
113. Turner A, Rabiu M. Patching for corneal abrasion. Cochrane Database Syst Rev. 2006(2):CD004764.
114. Federici TJ. The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease. Pharmacol Res. 2011;64(6):614-623.
115. Watson SL, Secker GA, Daniels JT. The effect of therapeutic human serum drops on corneal stromal wound-healing activity. Curr Eye Res. 2008;33(8):641-652.
116. Yoon KC, You IC, Im SK, Jeong TS, Park YG, Choi J. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. 2007;114(9):1637-1642.
117. Alió JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. 2007;114(7):1286-1293.
118. Aloe L, Tirassa P, Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol Res. 2008;57(4):253-258.
119. Tan MH, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea. 2006;25(3):352-355.
120. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet. 1998;351(9118):1783-1784.
121. Nishida T. The role of fibronectin in corneal wound healing explored by a physician-scientist. Jpn J Ophthalmol. 2012;56(5):417-431.
122. Dunn SP, Heidemann DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4. Ann N Y Acad Sci. 2010;1194:199-206.
123. Khokhar S, Natung T, Sony P, Sharma N, Agarwal N, Vajpayee RB. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea. 2005;24(6):654-660.
124. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109(4):694-703.
125. Letko E, Stechschulte SU, Kenyon KR, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001;119(5):659-663.
126. Pachigolla G, Prasher P, Di Pascuale MA, McCulley JP, McHenry JG, Mootha VV. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35(4):172-175.
127. Vote BJ, Elder MJ. Cyanoacrylate glue for corneal perforations: a description of a surgical technique and a review of the literature. Clin Experiment Ophthalmol. 2000;28(6):437-442.
128. Arslan S, Aydemir O, Guler M, Dagli AF. Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. Curr Eye Res. 2012;37(3):228-233.
129. Baker R, Urso-Baiarda F, Linge C, Grobbelaar A. Cutaneous scarring: a clinical review. Dermatol Res Pract. 2009;2009:625376.
130. Blair J, Hodge W, Al-Ghamdi S, et al. Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol. 2011;46(1):40-45.
131. Srinivasan M, Mascarenhas J, Rajaraman R, et al. Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130(2):143-150.
132. Holló G. Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules. Dev Ophthalmol. 2012;50:79-89.
133. Zhong H, Sun G, Lin X, Wu K, Yu M. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci. 2011;52(6):3136-3142.
134. Prata JA, Jr., Seah SK, Minckler DS, Baerveldt G, Lee PP, Heuer DK. Postoperative complications and short-term outcome after 5-Fluorouracil or mitomycin-C trabeculectomy. J Glaucoma. 1995;4(1):25-31.
135. Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs. 2006;66(3):321-340.
136. Kim JH, Kim MJ, Kim DY, Kim JY, Tchah H. Recurrent corneal hypertrophic scar after laser-assisted subepithelial keratectomy with mitomycin C treatment. Cornea. 2011;30(9):1030-1034.
137. Farid M, Morishige N, Lam L, Wahlert A, Steinert RF, Jester JV. Detection of corneal fibrosis by imaging second harmonic-generated signals in rabbit corneas treated with mitomycin C after excimer laser surface ablation. Invest Ophthalmol Vis Sci. 2008;49(10):4377-4383.
138. Ehrlich MI, Phinney RB, Mondino BJ, Pettit TH. Techniques of lamellar keratoplasty. Int Ophthalmol Clin. 1988;28(1):24-29.
139. Wood TO, Walker GG. Treatment of band keratopathy. Am J Ophthalmol. 1975;80(3 Pt 2):550.
140. Elkins BS, Casebeer JC, Kezirian GM. Sutureless homoplastic lamellar keratoplasty. J Refract Surg. 1997;13(2):185-187.
141. Alió JL, Javaloy J, Merayo J, Galal A. Automated superficial lamellar keratectomy augmented by excimer laser masked PTK in the management of severe superficial corneal opacities. Br J Ophthalmol. 2004;88(10):1289-1294.
142. Buratto L, Brint SF, Ferrari M. Complications. In: Buratto L, Brint SF, eds. LASIK: Principles and Techniques. Thorofare, NJ: SLACK, Inc.; 1998:120-1.
143. Alió JL, Agdeppa MC, Uceda-Montanes A. Femtosecond laser-assisted superficial lamellar keratectomy for the treatment of superficial corneal leukomas. Cornea. 2011;30(3):301-307.
144. Rasheed K, Rabinowitz YS. Superficial lamellar keratectomy using an automated microkeratome to excise corneal scarring caused by photorefractive keratectomy. J Cataract Refract Surg. 1999;25(9):1184-1187.
145. Najjar DM. Management of band keratopathy with excimer phototherapeutic keratectomy. Eye (Lond). 2006;20(2):252.
146. O'Brart DP, Gartry DS, Lohmann CP, Patmore AL, Kerr Muir MG, Marshall J. Treatment of band keratopathy by excimer laser phototherapeutic keratectomy: surgical techniques and long term follow up. Br J Ophthalmol. 1993;77(11):702-708.
147. Cavanaugh TB, Lind DM, Cutarelli PE, et al. Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy. Ophthalmology. 1999;106(5):971-976.
148. Elsahn AF, Rapuano CJ, Antunes VA, Abdalla YF, Cohen EJ. Excimer laser phototherapeutic keratectomy for keratoconus nodules. Cornea. 2009;28(2):144-147.
149. Awdeh RM, Abbey AM, Vroman DT, et al. Phototherapeutic keratectomy for the treatment of subepithelial fibrosis and anterior corneal scarring after descemet stripping automated endothelial keratoplasty. Cornea. 2012;31(7):761-763.
150. Stewart OG, Morrell AJ. Management of band keratopathy with excimer phototherapeutic keratectomy: visual, refractive, and symptomatic outcome. Eye (Lond). 2003;17(2):233-237.
151. Miller A, Solomon R, Bloom A, Palmer C, Perry HD, Donnenfeld ED. Prevention of recurrent Reis-Bücklers dystrophy following excimer laser phototherapeutic keratectomy with topical mitomycin C. Cornea. 2004;23(7):732-735.
152. Das S, Langenbucher A, Seitz B. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study. J Refract Surg. 2005;21(6):727-731.
153. Vinciguerra P, Camesasca FI. Custom phototherapeutic keratectomy with intraoperative topography. J Refract Surg. 2004;20(5):S555-563.
154. Ayres BD, Hammersmith KM, Laibson PR, Rapuano CJ. Phototherapeutic keratectomy with intraoperative mitomycin C to prevent recurrent anterior corneal pathology. Am J Ophthalmol. 2006;142(3):490-492.
155. Kim TI, Pak JH, Chae JB, Kim EK, Tchah H. Mitomycin C inhibits recurrent Avellino dystrophy after phototherapeutic keratectomy. Cornea. 2006;25(2):220-223.
156. Alió JL, Belda JI, Shalaby AM. Correction of irregular astigmatism with excimer laser assisted by sodium hyaluronate. Ophthalmology. 2001;108(7):1246-1260.
157. Dinh R, Rapuano CJ, Cohen EJ, Laibson PR. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology. 1999;106(8):1490-1497.
158. Rapuano CJ. Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: short-term clinical outcomes with and without an antihyperopia treatment and poor effectiveness of ultrasound biomicroscopic evaluation. Cornea. 2005;24(1):20-31.
159. Najjar DM, Cohen EJ, Rapuano CJ, Laibson PR. EDTA chelation for calcific band keratopathy: results and long-term follow-up. Am J Ophthalmol. 2004;137(6):1056-1064.
160. Arjamaa O. EDTA chelation for calcific band keratopathy. Am J Ophthalmol. 2005;139(1):216; author reply 216.
161. Lombardo M, De Santo MP, Lombardo G, et al. Surface quality of femtosecond dissected posterior human corneal stroma investigated with atomic force microscopy. Cornea. 2012;31(12):1369-1375.
162. Sarayba MA, Ignacio TS, Binder PS, Tran DB. Comparative study of stromal bed quality by using mechanical, IntraLase femtosecond laser 15- and 30-kHz microkeratomes. Cornea. 2007;26(4):446-451.
163. Jones MN, Armitage WJ, Ayliffe W, Larkin DF, Kaye SB. Penetrating and deep anterior lamellar keratoplasty for keratoconus: a comparison of graft outcomes in the United Kingdom. Invest Ophthalmol Vis Sci. 2009;50(12):5625-5629.
164. Shousha MA, Yoo SH, Kymionis GD, et al. Long-term results of femtosecond laser-assisted sutureless anterior lamellar keratoplasty. Ophthalmology. 2011;118(2):315-323.
165. Hoffart L, Proust H, Matonti F, Catanese M, Conrath J, Ridings B. Femtosecond-assisted anterior lamellar keratoplasty [in French]. J Fr Ophtalmol. 2007;30(7):689-694.
166. Mosca L, Fasciani R, Tamburelli C, et al. Femtosecond laser-assisted lamellar keratoplasty: early results. Cornea. 2008;27(6):668-672.
167. Utine CA, Tzu JH, Akpek EK. Lamellar keratoplasty using gamma-irradiated corneal lenticules. Am J Ophthalmol. 2011;151(1):170-174.
168. Daoud YJ, Smith R, Smith T, Akpek EK, Ward DE, Stark WJ. The intraoperative impression and postoperative outcomes of gamma-irradiated corneas in corneal and glaucoma patch surgery. Cornea. 2011;30(12):1387-1391.
169. Stevenson W, Cheng SF, Emami-Naeini P, et al. Gamma-irradiation reduces the allogenicity of donor corneas. Invest Ophthalmol Vis Sci. 2012;53(11):7151-7158.
170. Jhanji V, Sharma N, Vajpayee RB. Management of keratoconus: current scenario. Br J Ophthalmol. 2011;95(8):1044-1050.
171. Reinhart WJ, Musch DC, Jacobs DS, Lee WB, Kaufman SC, Shtein RM. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology. Ophthalmology. 2011;118(1):209-218.
172. Feizi S, Javadi MA, Jamali H, Mirbabaee F. Deep anterior lamellar keratoplasty in patients with keratoconus: big-bubble technique. Cornea. 2010;29(2):177-182.
173. Buzzonetti L, Laborante A, Petrocelli G. Refractive outcome of keratoconus treated by combined femtosecond laser and big-bubble deep anterior lamellar keratoplasty. J Refract Surg. 2011;27(3):189-194.
174. Farid M, Steinert RF. Deep anterior lamellar keratoplasty performed with the femtosecond laser zigzag incision for the treatment of stromal corneal pathology and ectatic disease. J Cataract Refract Surg. 2009;35(5):809-813.
175. Ardjomand N, Hau S, McAlister JC, et al. Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am J Ophthalmol. 2007;143(2):228-235.
176. Al-Torbak AA, Al-Motowa S, Al-Assiri A, et al. Deep anterior lamellar keratoplasty for keratoconus. Cornea. 2006;25(4):408-412.
177. Feizi S, Javadi MA, Rastegarpour A. Visual acuity and refraction after deep anterior lamellar keratoplasty with and without successful big-bubble formation. Cornea. 2010;29(11):1252-1255.
178. Fontana L, Parente G, Sincich A, Tassinari G. Influence of graft-host interface on the quality of vision after deep anterior lamellar keratoplasty in patients with keratoconus. Cornea. 2011;30(5):497-502.
179. Fontana L, Parente G, Tassinari G. Clinical outcomes after deep anterior lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am J Ophthalmol. 2007;143(1):117-124.
180. Han DC, Mehta JS, Por YM, Htoon HM, Tan DT. Comparison of outcomes of lamellar keratoplasty and penetrating keratoplasty in keratoconus. Am J Ophthalmol. 2009;148(5):744-751.
181. Javadi MA, Feizi S, Yazdani S, Mirbabaee F. Deep anterior lamellar keratoplasty versus penetrating keratoplasty for keratoconus: a clinical trial. Cornea. 2010;29(4):365-371.
182. Smadja D, Colin J, Krueger RR, et al. Outcomes of deep anterior lamellar keratoplasty for keratoconus: learning curve and advantages of the big bubble technique. Cornea. 2012;31(8):859-863.
183. Kubaloglu A, Sari ES, Unal M, et al. Long-term results of deep anterior lamellar keratoplasty for the treatment of keratoconus. Am J Ophthalmol. 2011;151(5):760-767.
184. Cheng YY, Visser N, Schouten JS, et al. Endothelial cell loss and visual outcome of deep anterior lamellar keratoplasty versus penetrating keratoplasty: a randomized multicenter clinical trial. Ophthalmology. 2011;118(2):302-309.
185. Fogla R, Padmanabhan P. Results of deep lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am J Ophthalmol. 2006;141(2):254-259.
186. Kubaloglu A, Koytak A, Sari ES, Akyol S, Kurnaz E, Ozerturk Y. Corneal endothelium after deep anterior lamellar keratoplasty and penetrating keratoplasty for keratoconus: a four-year comparative study. Indian J Ophthalmol. 2012;60(1):35-40.
187. Sarnicola V, Toro P, Sarnicola C, Sarnicola E, Ruggiero A. Long-term graft survival in deep anterior lamellar keratoplasty. Cornea. 2012;31(6):621-626.
188. Olson EA, Tu EY, Basti S. Stromal rejection following deep anterior lamellar keratoplasty: implications for postoperative care. Cornea. 2012;31(9):969-973.
189. Parmar P, Salman A, Jesudasan CA. Visual outcome and corneal topography after eccentric "shaped" corneal grafts. Cornea. 2009;28(4):379-384.
190. Huang T, Wang Y, Ji J, Gao N, Chen J. Evaluation of different types of lamellar keratoplasty for treatment of peripheral corneal perforation. Graefes Arch Clin Exp Ophthalmol. 2008;246(8):1123-1131.
191. Afshari NA, Duncan SM, Tanhehco TY, Azar DT. Optimal size and location for corneal rotational autografts: a simplified mathematical model. Arch Ophthalmol. 2006;124(3):410-413.
192. Bertelmann E, Hartmann C, Scherer M, Rieck P. Outcome of rotational keratoplasty: comparison of endothelial cell loss in autografts vs allografts. Arch Ophthalmol. 2004;122(10):1437-1440.
193. Mashor RS, Rootman DB, Bahar I, Singal N, Slomovic AR, Rootman DS. Outcomes of deep anterior lamellar keratoplasty versus intralase enabled penetrating keratoplasty in keratoconus. Can J Ophthalmol. 2011;46(5):403-407.
194. Chamberlain WD, Rush SW, Mathers WD, Cabezas M, Fraunfelder FW. Comparison of femtosecond laser-assisted keratoplasty versus conventional penetrating keratoplasty. Ophthalmology. 2011;118(3):486-491.
195. Chan CC, Ritenour RJ, Kumar NL, Sansanayudh W, Rootman DS. Femtosecond laser-assisted mushroom configuration deep anterior lamellar keratoplasty. Cornea. 2010;29(3):290-295.
196. Ignacio TS, Nguyen TB, Chuck RS, Kurtz RM, Sarayba MA. Top hat wound configuration for penetrating keratoplasty using the femtosecond laser: a laboratory model. Cornea. 2006;25(3):336-340.
197. Kutzscher EM, Sorenson AL, Goodman DF. Penetrating keratoplasty performed by residents. Arch Ophthalmol. 2004;122(9):1333-1336.
198. Moorthy S, Graue E, Jhanji V, Constantinou M, Vajpayee RB. Microbial keratitis after penetrating keratoplasty: impact of sutures. Am J Ophthalmol. 2011;152(2):189-194 e182.
199. Hood CT, Lee BJ, Jeng BH. Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty. Cornea. 2011;30(6):624-628.
200. Chamberlain W, Omid N, Lin A, Farid M, Gaster RN, Steinert RF. Comparison of corneal surface higher-order aberrations after endothelial keratoplasty, femtosecond laser-assisted keratoplasty, and conventional penetrating keratoplasty. Cornea. 2012;31(1):6-13.
201. Armitage WJ, Dick AD, Bourne WM. Predicting endothelial cell loss and long-term corneal graft survival. Invest Ophthalmol Vis Sci. 2003;44(8):3326-3331.
202. Park CY, Lee JK, Gore PK, Lim CY, Chuck RS. Keratoplasty in the United States: a 10-year review from 2005 through 2014. Ophthalmology. 2015;122(12):2432-2442.
203. Aldave AJ, DeMatteo J, Glasser DB, et al. Report of the Eye Bank Association of America medical advisory board subcommittee on fungal infection after corneal transplantation. Cornea. 2013;32(2):149-154.
204. Edelstein SL, DeMatteo J, Stoeger CG, Macsai MS, Wang CH. Report of the Eye Bank Association of America medical review subcommittee on adverse reactions reported From 2007 to 2014. Cornea. 2016;35(7):917-926.
205. Vislisel JM, Goins KM, Wagoner MD, et al. Incidence and outcomes of positive donor corneoscleral rim fungal cultures after keratoplasty. Ophthalmology. 2017;124(1):36-42.
206. Brothers KM, Shanks RMQ, Hurlbert S, Kowalski RP, Tu EY. Association between fungal contamination and eye bank-prepared endothelial keratoplasty tissue: temperature-dependent risk factors and antifungal supplementation of optisol-gentamicin and streptomycin. JAMA Ophthalmol. 2017;135(11):1184-1190.
207. Wilhelmus KR, Hassan SS. The prognostic role of donor corneoscleral rim cultures in corneal transplantation. Ophthalmology. 2007;114(3):440-445.
208. Keyhani K, Seedor JA, Shah MK, Terraciano AJ, Ritterband DC. The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea. 2005;24(3):288-291.
209. Barber JC. Keratoprosthesis: past and present. Int Ophthalmol Clin. 1988;28(2):103-109.
210. Cardona H, DeVoe AG. Prosthokeratoplasty. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(2):271-280.
211. Falcinelli G, Falsini B, Taloni M, Colliardo P. Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases. Arch Ophthalmol. 2005;123(10):1319-1329.
212. Hicks CR, Crawford GJ, Tan DT, et al. AlphaCor cases: comparative outcomes. Cornea. 2003;22(7):583-590.
213. Pujari S, Siddique SS, Dohlman CH, Chodosh J. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea. 2011;30(12):1298-1303.
214. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640-651.
215. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119(8):1530-1538.
216. Zerbe BL, Belin MW, Ciolino JB. Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113(10):1779.
217. Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118(8):1543-1550.
218. Harissi-Dagher M, Dohlman CH. The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008;43(2):165-169.
219. Iyer G, Srinivasan B, Gupta J, et al. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication. Cornea. 2011;30(10):1083-1087.
220. Khan BF, Harissi-Dagher M, Pavan-Langston D, Aquavella JV, Dohlman CH. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol. 2007;125(6):745-749.
221. Pavan-Langston D, Dohlman CH. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology. 2008;115(2 Suppl):S21-23.
222. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol. 2007;144(2):227-231.
223. Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145(3):438-444.
224. Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology. 2001;108(3):461-469.
225. Aquavella JV, Gearinger MD, Akpek EK, McCormick GJ. Pediatric keratoprosthesis. Ophthalmology. 2007;114(5):989-994.
226. Fung SSM, Jabbour S, Harissi-Dagher M, et al. Visual outcomes and complications of type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review. Ophthalmology. 2018;125(2):153-160.
227. Ciolino JB, Ament JW, Zerbe BL, Belin MW. Etiology of keratoprosthesis loss: results from the Boston Keratoprosthesis Multicenter Study. Invest Ophthalmol Vis Sci. 2008;49:E-Abstract 5712.
228. Verdejo-Gomez L, Pelaez N, Gris O, Guell JL. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surg Lasers Imaging. 2011;42(6):446-452.
229. Aravena C, Yu F, Aldave AJ. Long-term visual outcomes, complications, and retention of the Boston type I keratoprosthesis. Cornea. 2018;37(1):3-10.
230. Dohlman CH, Grosskreutz CL, Chen TC, et al. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma. 2010;19(2):111-115.
231. Patel S, Takusagawa H, Shen L, Dohlman C, Grosskreutz C. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol. 2012;154(1):207-208; author reply 208-209.
232. Kamyar R, Weizer JS, de Paula FH, et al. Glaucoma associated with Boston type I keratoprosthesis. Cornea. 2012;31(2):134-139.
233. Alexander JK, Basak SK, Padilla MD, Yu F, Aldave AJ. International outcomes of the Boston type I keratoprosthesis in Stevens-Johnson syndrome. Cornea. 2015;34(11):1387-1394.
234. Biber JM, Skeens HM, Neff KD, Holland EJ. The Cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea. 2011;30(7):765-771.
235. Srikumaran D, Munoz B, Aldave AJ, et al. Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology. 2014;121(11):2159-2164.
236. Yaghouti F, Nouri M, Abad JC, Power WJ, Doane MG, Dohlman CH. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20(1):19-23.
237. Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007;26(1):9-15.
238. Mazzotta C, Traversi C, Baiocchi S, Barabino S, Mularoni A. Phenotypic spectrum of granular corneal dystrophy type II in two italian families presenting an unusual granular corneal dystrophy type I clinical appearance. Case Rep Ophthalmol Med. 2015;2015:703418.
239. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221-e1234.
240. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214-221.
241. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614-618.
242. Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012;60(5):423-427.